REVOLUTION MEDICINES, INC.

Profile

Company Names

REVOLUTION MEDICINES, INC.

Addresses

700 SAGINAW DR, REDWOOD CITY, CA 94063

Phone Numbers

650-481-6808

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$204,242,977.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-06-05 
$100,287,058.00 
$100,287,058.00 
$0.00 
Equity 
2
2018-03-23 
$56,430,920.00 
$56,430,920.00 
$0.00 
Equity 
1
2014-12-10 
$47,524,999.00 
$70,024,999.00 
$22,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ELIZABETH 
 
ANDERSON 
DIRECTOR
MIDLAND BANCSHARES INC   |  REVOLUTION MEDICINES, INC.   |  ARO BIOTHERAPEUTICS CO   |  RECONNAISSANCE ENERGY AFRICA LTD   |  RECONNAISSANCE ENERGY AFRICA LTD.
MICHAEL 
 
BONNEY 
DIRECTOR
REVOLUTION MEDICINES, INC.   |  MAGENTA THERAPEUTICS, INC.   |  GEORGETOWN BROADBAND LLC
ALEXIS 
 
BORISY 
DIRECTOR
FOUNDATION MEDICINE, INC.   |  FORMA THERAPEUTICS HOLDINGS LLC   |  BLUEPRINT MEDICINES CORP   |  EDITAS MEDICINE, INC.   |  REVOLUTION MEDICINES, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  MAGENTA THERAPEUTICS, INC.   |  CELSIUS THERAPEUTICS, INC.   |  TANGO THERAPEUTICS, INC.   |  RELAY THERAPEUTICS, INC.   |  CURIE BIO SERIES A FUND I, L.P.   |  CURIE BIO SEED FUND II, L.P.   |  CURIE BIO SEED FUND II-A, L.P.
NEIL 
 
EXTER 
DIRECTOR
SEVENTH SENSE BIOSYSTEMS, INC.   |  CORIDEA NC1, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ELEMENT SCIENCE, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  GOLDFINCH BIOPHARMA, INC.   |  PLIANT THERAPEUTICS, INC.   |  THIRD ROCK VENTURES V, L.P.   |  REVOLUTION MEDICINES, INC.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
MARK 
A. 
GOLDSMITH 
EXECUTIVE OFFICER, DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  IGENICA INC   |  REVOLUTION MEDICINES, INC.
MARGARET 
 
HORN 
EXECUTIVE OFFICER
REVOLUTION MEDICINES, INC.
STEVE 
 
KELSEY 
EXECUTIVE OFFICER
REVOLUTION MEDICINES, INC.
LAURENCE 
 
LASKY 
DIRECTOR
CALITHERA BIOSCIENCES, INC.   |  EFFECTOR THERAPEUTICS, INC.   |  RIBON THERAPEUTICS, INC.   |  REVOLUTION MEDICINES, INC.
RYAN 
 
MARTINS 
EXECUTIVE OFFICER
REVOLUTION MEDICINES, INC.
VINCENT 
 
MILLER 
DIRECTOR
REVOLUTION MEDICINES, INC.
THILO 
 
SCHROEDER 
DIRECTOR
BLUEPRINT MEDICINES CORP   |  IMAGINAB, INC.   |  IDEAYA BIOSCIENCES, INC.   |  REVOLUTION MEDICINES, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  CIRCLE PHARMA, INC.   |  ALTEROME THERAPEUTICS, INC.   |  NEXTECH VII ONCOLOGY SCSP   |  NEXTECH CROSSOVER I SCSP   |  NEXTECH VII CARRY SCSP   |  NEXTECH CROSSOVER I CARRY SCSP   |  NEXTECH VIII SCSP   |  STIPPLE BIO, INC.
BARBARA 
 
WEBER 
DIRECTOR
REVOLUTION MEDICINES, INC.   |  FOG PHARMACEUTICALS, INC.   |  TANGO THERAPEUTICS, INC.
LUAN 
 
WILFONG 
EXECUTIVE OFFICER
REVOLUTION MEDICINES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-11-15
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-06-05 
2018-07-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-23 
2016-12-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#